# The effects of elevated phosphate on the kidney - damaging the gatekeeper

**Authors:** Tanecia Mitchell, Vivek Verma, Abul Fajol, Christian Faul

PMC · DOI: 10.1007/s00424-026-03160-5 · 2026-03-30

## TL;DR

This paper explores how high phosphate levels can damage the kidneys, contributing to chronic kidney disease and kidney stones.

## Contribution

The paper introduces the idea that elevated renal tubular phosphate, not just serum phosphate, drives kidney injury.

## Key findings

- Tubular phosphate can form microcrystals that damage kidney cells and cause calcification.
- Hyperphosphaturia may contribute to kidney damage in both CKD and genetic diseases.
- High dietary phosphate intake could induce kidney damage even without CKD.

## Abstract

The kidney is a major regulator of phosphate metabolism. The body can lower systemic phosphate levels by increasing renal phosphate excretion, and kidney injury results in elevated serum phosphate concentrations (hyperphosphatemia). Chronic kidney disease (CKD) is associated with various organ injuries, including vascular calcification and cardiovascular disease, where hyperphosphatemia acts as a pathologic driver. Here we discuss hyperphosphatemia not as a consequence of kidney disease but as a potential contributor to kidney damage. We describe how increases in renal tubular phosphate levels (hyperphosphaturia), rather than hyperphosphatemia contribute to kidney injury in CKD. Tubular phosphate can form microcrystals with calcium which damages renal epithelial cells, induces fibrosis and inflammation, and causes parenchymal calcification. Calcium phosphate microcrystals can grow and form larger deposits in the renal collecting system, and potentially contribute to the formation of kidney stones. Therefore, hyperphosphaturia might not only contribute to kidney damage in CKD, but could also cause kidney injury in genetic diseases with reduced renal phosphate uptake. Finally, since high dietary phosphate intake increases renal phosphate excretion, we discuss if prolonged phosphate loading in the absence of CKD can induce kidney damage. We propose that a better understanding of the pathologic actions of phosphate on the kidney will help to identify novel therapeutic strategies to prevent renal injury and disease progression in patients with CKD and in other renal conditions, such as kidney stone formation. Lowering dietary phosphate intake might not only have reno-protective effects in patients with pre-existing kidney damage but also in healthy individuals.

## Linked entities

- **Chemicals:** phosphate (PubChem CID 1061)
- **Diseases:** chronic kidney disease (MONDO:0005300), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, POU1F1 (POU class 1 homeobox 1) [NCBI Gene 5449] {aka CPHD1, GHF-1, PIT1, POU1F1a, Pit-1}, LRP2 (LDL receptor related protein 2) [NCBI Gene 4036] {aka DBS, GP330, LRP-2}, ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) [NCBI Gene 5167] {aka ARHR2, COLED, M6S1, NPP1, NPPS, PC-1}, SLC34A1 (solute carrier family 34 member 1) [NCBI Gene 6569] {aka FRTS2, HCINF2, NAPI-3, NPHLOP1, NPT2, NPTIIa}, Spp1 (secreted phosphoprotein 1) [NCBI Gene 20750] {aka 2AR, Apl-1, BNSP, BSPI, Bsp, ETA-1}, TNAP [NCBI Gene 445341], Slc34a1 (solute carrier family 34 (sodium phosphate), member 1) [NCBI Gene 20505] {aka NaPi-IIa, Npt2, Npt2a, Slc17a2}, TRPV5 (transient receptor potential cation channel subfamily V member 5) [NCBI Gene 56302] {aka CAT2, ECAC1, OTRPC3}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, SLC5A2 (solute carrier family 5 member 2) [NCBI Gene 6524] {aka SGLT2}, COL4A3 (collagen type IV alpha 3 chain) [NCBI Gene 1285] {aka ATS2, ATS3, ATS3A, ATS3B, BFH2}, FGF23 (fibroblast growth factor 23) [NCBI Gene 8074] {aka ADHR, FGFN, HFTC2, HPDR2, HYPF, PHPTC}, KL (klotho) [NCBI Gene 9365] {aka HFTC3, KLA}, PTH1R (parathyroid hormone 1 receptor) [NCBI Gene 5745] {aka EKNS, PFE, PTHR, PTHR1}, SLC34A3 (solute carrier family 34 member 3) [NCBI Gene 142680] {aka HHRH, NPT2C, NPTIIc}, AHSG (alpha 2-HS glycoprotein) [NCBI Gene 197] {aka A2HS, AHS, APMR1, FETUA, HSGA}, Spp1 (secreted phosphoprotein 1) [NCBI Gene 25353] {aka OSP}, Ahsg (alpha-2-HS-glycoprotein) [NCBI Gene 11625], SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, ABCC6 (ATP binding cassette subfamily C member 6) [NCBI Gene 368] {aka ABC34, ARA, EST349056, GACI2, MLP1, MOAT-E}, AVPR2 (arginine vasopressin receptor 2) [NCBI Gene 554] {aka ADHR, DI1, DIR, DIR3, NDI, NDI1}
- **Diseases:** injury (MESH:D014947), dehydration (MESH:D003681), proteinuria (MESH:D011507), infection stones (MESH:D007239), PXE (MESH:D011561), GACI (MESH:C537440), ARHR2 (MESH:C567647), AKI (MESH:D058186), acidosis (MESH:D000138), tubular damage (MESH:D000230), organ injuries (MESH:D009102), Hyperphosphaturia (MESH:D007015), primary hyperparathyroidism (MESH:D049950), tumor-induced osteomalacia (MESH:C537751), urinary tract infections (MESH:D014552), glomerular injury (MESH:D007674), Mendelian monogenic stone disease (MESH:D001744), PKD (MESH:D007690), Alport Syndrome (MESH:D009394), fibrosis (MESH:D005355), bone damage (MESH:D001847), Obesity (MESH:D009765), renal calcification (MESH:C565478), type-2 diabetes (MESH:D003924), cancer of the bladder and bile duct (MESH:D001650), cancer (MESH:D009369), glycosuria (MESH:D006029), renal phosphate wasting (MESH:D019282), nephrolithiasis (MESH:D053040), CKDu (MESH:D000092702), cyst (MESH:D003560), Nephrocalcinosis (MESH:D009397), autosomal dominant hypophosphatemic rickets (MESH:C562791), tumor lysis syndrome (MESH:D015275), nephrotic syndrome (MESH:D009404), cardiovascular disease (MESH:D002318), Vascular calcifications (MESH:D061205), hyperglycemia (MESH:D006943), IIH (MESH:C562999), Calcium phosphate stones (MESH:D007669), Hyperphosphatemia (MESH:D054559), Hyperphosphatemic tumoral calcinosis (MESH:C566870), calcify (MESH:D018333), tubulointerstitial renal disease (OMIM:162000), Calcifications (MESH:D002114), hypertension (MESH:D006973), IgA nephropathy (MESH:D005922), decline in kidney function (MESH:D007680), stone formation (MESH:D058426), osteomalacia (MESH:D010018), Genetic diseases (MESH:D030342), glomerulonephritis (MESH:D005921), renal failure (MESH:D051437), HHRH (MESH:D053098), inflammation (MESH:D007249), ESRD (MESH:D007676), rhabdomyolysis (MESH:D012206), bone fractures (MESH:D050723), reperfusion injury (MESH:D015427), diabetes (MESH:D003920)
- **Chemicals:** 1,25D (-), G-3-P (MESH:C029620), folic acid (MESH:D005492), Phosphate (MESH:D010710), Ca (MESH:D002118), Pyrophosphate (MESH:C107241), Magnesium (MESH:D008274), Calcium phosphate (MESH:C020243), sodium (MESH:D012964), diphosphonate (MESH:D004164), calcium monohydrogen phosphate (MESH:C485829), citrate (MESH:D019343), Pemigatinib (MESH:C000705477), glyoxylate (MESH:C031150), hydroxyproline (MESH:D006909), blood glucose (MESH:D001786), Pi (MESH:D010716), Cy (MESH:D003545), Carbonate apatite (MESH:C030782), apatite (MESH:D001031), Whitlockite (MESH:C021767), Tricalcium phosphate (MESH:C018392), AMP (MESH:D000249), vitamin D (MESH:D014807), ATP (MESH:D000255), CPMs (MESH:C037534), polyphosphate (MESH:D011122), adenine (MESH:D000225), magnesium ammonium phosphate (MESH:D000069877), Fluoride (MESH:D005459), Infigratinib (MESH:C568950), Erdafitinib (MESH:C000604580), hydroxyapatite (MESH:D017886), fluorapatite (MESH:C025105), ammonia (MESH:D000641), CaOx (MESH:D002129), alkali (MESH:D000468), sodium phosphate (MESH:C018279), oxalate (MESH:D010070), glucose (MESH:D005947), inulin (MESH:D007444), Phosphorus (MESH:D010758), calcium carbonate (MESH:D002119)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Felis catus (cat, species) [taxon 9685], Canis lupus familiaris (dog, subspecies) [taxon 9615], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S129P, Ser192Leu

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13033467/full.md

---
Source: https://tomesphere.com/paper/PMC13033467